Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK study confirms importance of fibrinolysis in women

This article was originally published in Clinica

Executive Summary

Low fibrinolytic activity may play a part in female heart disease. The Northwick Park heart study found that low fibrinolytic activity was linked to ischaemic heart disease in women. The same study proved a link in men in 1993 but very few of the 695 of the women who enrolled in the 1970s have died of ischaemic heart disease. However, those that did had significantly lower fibrinolytic activity and higher blood pressure than those who remained alive.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT088387

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel